Nekvnro Pain Relief Cream

Manufacturer
Guoyu Trading Co., Ltd.
Effective date
2024-10-23
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:30:11

Label at a glance#

ProductNekvnro Pain Relief Cream
Active ingredientARNICA MONTANA
Label structure12 sections

Dosage and administration

Apply a thin layer of dermfree cream to the affected area as soon as possible after minor injury. Repeat 3 times a day or as needed. If heat or ice is applied, wait 5 minutes before applying dermfree cream.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Arnica montana HPUS 7%

Purpose

OTC - PURPOSE SECTION

Relieves muscle pain &stiffness, swelling from injuries, discoloration from bruises

Use

INDICATIONS & USAGE SECTION

temporarily relieves muscle pain and stiffness due to:
■minor injuries

■overexertion

■falls reduces symptoms of bruising such as:

■pain ■swelling

■discoloration

Warnings

WARNINGS SECTION

For external use only,Do not use if you are allergic to dermfree.cream or to any of this product's inactive ingredients

Do not use

OTC - DO NOT USE SECTION

if you are allergic to dermfree.cream or to any of this product's inactive ingredients

When Using

OTC - WHEN USING SECTION

this product avoid contact with eyes, mucous membranes, wounds, damaged or irritated skin. use only as directed dryness or irritation may occur
do not tightly wrap or bandage the treated area
do not apply heat or ice to treated area immediately before or after use

Stop Use

OTC - STOP USE SECTION

ocondition persists for more than 3 days or worsens
osymptoms clear up and occur again within a few days.

Ask Doctor

OTC - ASK DOCTOR SECTION

ocondition persists for more than 3 days or worsens
osymptoms clear up and occur again within a few days.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

if swallowed,get medical help Or contact a poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply a thin layer of dermfree cream to the affected area as soon as possible after minor injury. Repeat 3 times a day or as needed. If heat or ice is applied, wait 5 minutes before applying dermfree cream.

Inactive ingredients

INACTIVE INGREDIENT SECTION

purified water,Alcohol, carbomer,sodium hydroxide, Vanillyl butyl ether

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1122334455667788991010

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
84844-003-012026-01-29C16284748780-149896155-beef-586f-e063-e6dba90add9084844-003
84844-003-022026-01-29C16284748780-149896155-beef-586f-e063-e6dba90add9084844-003

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84844-003-01Nekvnro Pain Relief Cream80 g in 1 BOTTLECREAM801
84844-003-02Nekvnro Pain Relief Cream100 g in 1 BOTTLECREAM1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84844-003NEKVNRO PAIN RELIEF CREAM (PAIN RELIEF CREAM) CREAM [GUOYU TRADING CO., LTD.]12 package rows20241029_2522adca-3a26-80ed-e063-6394a90a0d26.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84844-00384844-003-01, 84844-003-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2522adca-3a27-80ed-e063-6394a90a0d262522adca-3a26-80ed-e063-6394a90a0d262024-10-23WarningsExact identifier
spl id: 2522adca-3a27-80ed-e063-6394a90a0d26
spl set id: 2522adca-3a26-80ed-e063-6394a90a0d26

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.